SRINIVAS AKKARAJU Insider Trading
Get free email notifications about insider trading for SRINIVAS AKKARAJU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SRINIVAS AKKARAJU. SRINIVAS AKKARAJU is a Director in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Address: C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES STREET NEW YORK 10013 NY
Companies in which SRINIVAS AKKARAJU is an Insider
INTERCEPT PHARMACEUTICALS, INC.
Trading Symbol: ICPTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 2,368 shares
Current Value: $268,934
Latest Transaction: Dec 19 2013
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of SRINIVAS AKKARAJU
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 19 2013 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Sell | S | 55.53 | 260 | 14,437 | 2,368 | 2.6 K to 2.4 K (-9.89 %) |
Oct 21 2013 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 0.00 | 324 | 0 | 1,298 | |
Oct 21 2013 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 0.00 | 324 | 0 | 2,628 | 2.3 K to 2.6 K (+14.06 %) |
Jul 16 2013 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 0.00 | 325 | 0 | 1,622 | |
Jul 16 2013 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 0.00 | 325 | 0 | 2,304 | 2 K to 2.3 K (+16.42 %) |
May 09 2013 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 31.90 | 1,980 | 63,162 | 1,980 | |
May 09 2013 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 1,330 | 0 | 1,979 | 649 to 2 K (+204.93 %) |